Evidence map›Paper›PMID 26840306›Full record

ArticleInternational journal of molecular sciences2016

Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish.

Anja Bühler, Monika Kustermann, Tiziana Bummer, Wolfgang Rottbauer, Marco Sandri, Steffen Just

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Gene alteration in zebrafish exposed to a mixture of substances of abuse.Environmental pollution (Barking, Essex : 1987) · 2021
    Article
  7. Exercise Training-IncreasedFrontiers in aging neuroscience · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Ftr82 Is Critical for Vascular Patterning during Zebrafish Development.International journal of molecular sciences · 2017
    Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anja BühlerMolecular Cardiology, University of Ulm, 89081 Ulm, Germany. anja.buehler@uniklinik-ulm.de.
Monika KustermannMolecular Cardiology, University of Ulm, 89081 Ulm, Germany. monika.forster@uni-ulm.de.
Tiziana BummerMolecular Cardiology, University of Ulm, 89081 Ulm, Germany. tiziana.bummer@uni-ulm.de.
Wolfgang RottbauerDepartment of Internal Medicine II, University of Ulm, 89081 Ulm, Germany. wolfgang.rottbauer@uniklinik-ulm.de.
Marco SandriDepartment of Biomedical Sciences, University of Padova, 35129 Padova, Italy. marco.sandri@unipd.it.
Steffen JustMolecular Cardiology, University of Ulm, 89081 Ulm, Germany. steffen.just@uniklinik-ulm.de.
Universität Ulm · DEUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orchestrated protein synthesis and degradation is fundamental for proper cell function. In muscle, impairment of proteostasis often leads to severe cellular defects finally interfering with contractile function. Here, we analyze for the first time the role of Atrogin-1, a muscle-specific E3 ubiquitin ligase known to be involved in the regulation of protein degradation via the ubiquitin proteasome and the autophagy/lysosome systems, in the in vivo model system zebrafish (Danio rerio). We found that targeted inactivation of zebrafish Atrogin-1 leads to progressive impairment of heart and skeletal muscle function and disruption of muscle structure without affecting early cardiogenesis and skeletal muscle development. Autophagy is severely impaired in Atrogin-1-deficient zebrafish embryos resulting in the disturbance of the cytoarchitecture of cardiomyocytes and skeletal muscle cells. These observations are consistent with molecular and ultrastructural findings in an Atrogin-1 knockout mouse and demonstrate that the zebrafish is a suitable vertebrate model to study the molecular mechanisms of Atrogin-1-mediated autophagic muscle pathologies and to screen for novel therapeutically active substances in high-throughput in vivo small compound screens (SCS).

Indexed as

AnimalsAutophagyF-Box ProteinsHeart FailureMuscle, SkeletalMuscular DiseasesMyocytes, CardiacZebrafishZebrafish ProteinsF-Box Proteinsfbxo32 protein, zebrafishZebrafish ProteinsAtrogin-1autophagyheart failuremyopathyzebrafish

Identifiers

PMID26840306
PMCPMC4783921
OpenAlexW2256802025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.